Today’s Ethereum news is full of renewed selling pressure, with ETH falling below key support areas and market sentiment deteriorating in the crypto market. On-Today’s Ethereum news is full of renewed selling pressure, with ETH falling below key support areas and market sentiment deteriorating in the crypto market. On-

Ethereum News Today: Vitalik Buterin Continues To Sell as Investors Eye Next Price Target Of $2,200

2026/02/10 13:24
5 min read

Today’s Ethereum news is full of renewed selling pressure, with ETH falling below key support areas and market sentiment deteriorating in the crypto market. On-chain statistics indicate further selling by the big sellers, contributing to short-term panic over the price movement. With the spread of Ethereum news all over the crypto news platforms, there are those investors who are beginning to seek alternative sources of stability and growth other than ETH. One project drawing attention is Remittix, which has raised over $29.1 million while rolling out real products during a volatile period for digital assets.

Ethereum News Today: As Vitalik Sales Shake Market Confidence

Source: Trading View

Ethereum News Today: Vitalik Buterin Continues To Sell as Investors Eye Next Price Target Of $2,200

The Ethereum news has been cautious following reports by on-chain data indicating that there are still ETH sales associated with co-founder Vitalik Buterin. Lookonchain, wallets belonging to the Ethereum developer sold thousands of ETH in a few days when the price dropped to less than $2,000. First data exchange of 2,961 ETH around the price of $2,228, and then the total sales of 6,183 ETH at the average price of around $2,140 came as the downside momentum gained momentum.

This Ethereum news arrived during a broader wave of deleveraging across altcoins. ETH has underperformed Bitcoin and slipped well below the $2,100 level that many traders viewed as key support. At the time of writing, the world’s second-largest cryptocurrency was trading near $1,900, down over 30 percent in a week. This sharp move has increased market volatility and fueled bearish crypto analysis across the space.

Increased institutional repositioning has also been noted in Ethereum news. According to a CryptoQuant report, U.S. investors disposed of ETH at a discount, causing the Coinbase Premium Index to drop to its lowest point since mid 2022. That tendency is commonly indicative of institutional de-risking, as opposed to retail panic. Further transactions on the chain proved the presence of other large entities that sold to settle debts, with hardly any long-term buyers entering the market to buy during the downturn.

Although the fundamentals of blockchain technology, smart contracts, and Ethereum Layer 2 are high, the market sentiment in the near term is weak. Investors are now viewing $2,200 as a price point to regain as a critical price target before they can regain confidence. Until then, Ethereum news is likely to remain dominated by caution, rotation, and selective risk-taking across decentralized finance DeFi.

Why Remittix Is Gaining Attention As ETH Struggles

While Ethereum news remains focused on selling pressure, Remittix is moving in the opposite direction by showing clear momentum and execution. The project has already sold over 708 million tokens at $0.123 each, placing it above 97% of total supply sold. This level of demand stands out during a crypto bear market phase when many projects are slowing down. Remittix is attracting a wave of investors eager to participate in the future of payments with its unique 300% bonus offer and practical utility in the crypto space.

A major driver of interest is product delivery. The wallet is already accessible on the Apple App Store, where one can store, send, and manage assets securely. Google Play will be launched in the near future, which will widen the coverage with the increase in crypto adoption across the world. This ecosystem is not theoretical, and unlike many other early-stage digital assets, it is already in operation.

Trust has been a significant factor as well. The group has gone through the entire KYC certification process with CertiK and has the top Pre-Launch rating on CertiK Skynet with a Grade A of 80.09. Over 24,000 community ratings demonstrate increased confidence at a time when there is increased concern about crypto regulation, and market sentiment is changing.

The fact that the PayFi platform will be launched on February 9, 2026, is another dimension of practical value. This release will enable crypto-to-fiat payments, bridging Web3 with everyday finance and business use cases. As investors search for the next XRP-style payments narrative, urgency continues to build.

Key developments driving momentum include:

  • Over $29.1 million raised with limited tokens remaining before sellout
  • Wallet is live on the Apple App Store, with Google Play release in progress
  • PayFi crypto to fiat platform scheduled for February 9, 2026
  • First two CEX listings confirmed, with two more already secured
  • Private 300% email-only bonus accelerating investor demand

Why Ethereum Uncertainty Is Driving Capital Rotation

Ethereum news today is indicative of a market in crossroads. Ongoing selling of influential wallets has rocked confidence, despite the underlying network basics in the long-term. As ETH continues to fall back to lost levels and institutions de-exposing, lots of crypto investors are opting to rotate capital instead of waiting through deeper drawdowns.

Projects with actual execution, good tokenomics, and utility are distinguished in this environment. As Ethereum works through its current correction, the contrast between price pressure and progress elsewhere is becoming harder to ignore. This dynamic explains why capital is shifting toward alternatives that combine momentum with real-world impact as the next phase of the crypto market takes shape.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io/

Socials: https://linktr.ee/remittix

Comments
Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$2,017.44
$2,017.44$2,017.44
-2.08%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26